Medicare Enrolled

Dr. Saud Alvi, M.D.,FACR

Rheumatology · Toledo, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3830 WOODLEY RD STE B, Toledo, OH 43606
4194739380
Registered in NPPES since 2008
NPI: 1609031509 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alvi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alvi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alvi

Dr. Saud Alvi is a rheumatology specialist in Toledo, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Alvi performed 27,688 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Alvi received a total of $7,441 from 27 pharmaceutical and/or device companies across 222 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alvi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 16% volume in OH $7,441 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
27,688
Medicare services
Top 16% in OH for rheumatology
Not available
Unique patients (not deduplicated)
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
12,450 $11 $49
Denosumab injection (Prolia/Xgeva) 6,361 $17 $32
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
6,325 $26 $165
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,043 $82 $208
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
292 $5 $12
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
258 $89 $253
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
230 $8 $10
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
174 $20 $54
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
113 $10 $48
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
85 $35 $119
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
81 $52 $165
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
69 $52 $141
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
46 $11 $42
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
32 $120 $320
Knee X-ray, 3 views
An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures.
29 $30 $67
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
29 $4 $12
X-ray of hand, 2 views
An X-ray imaging test of the hand using two different angles to visualize the bones and joints.
28 $23 $49
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
24 $26 $65
X-ray of upper spine, 2-3 views
An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures.
19 $24 $62
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
68.7% high complexity
25.6% medium
5.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,441
Total received (2018-2024)
Avg $1,063/year across 7 years
Top 32% in OH for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
222
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$518
2023
$726
2022
$467
2021
$679
2020
$124
2019
$247
2018
$4,679

Payments by company (2024)

Janssen Biotech, Inc.
$91
ABBVIE INC.
$90
Amgen Inc.
$83
E.R. Squibb & Sons, L.L.C.
$60
GlaxoSmithKline, LLC.
$55
PFIZER INC.
$51
Novartis Pharmaceuticals Corporation
$28
AstraZeneca Pharmaceuticals LP
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Radius Health, Inc.
$18
Top 3 companies account for 50.9% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$3,877
Amgen Inc.
$533
PFIZER INC.
$426
Novartis Pharmaceuticals Corporation
$421
E.R. Squibb & Sons, L.L.C.
$280
AbbVie Inc.
$270
Janssen Biotech, Inc.
$248
GlaxoSmithKline, LLC.
$234
ABBVIE INC.
$173
AstraZeneca Pharmaceuticals LP
$165
Genentech USA, Inc.
$159
Horizon Therapeutics plc
$96
Regeneron Healthcare Solutions, Inc.
$75
Antares Pharma, Inc.
$67
Mallinckrodt Hospital Products Inc.
$66
AbbVie, Inc.
$50
Lilly USA, LLC
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
GENZYME CORPORATION
$38
Aurinia Pharma U.S., Inc.
$36
Radius Health, Inc.
$31
Horizon Pharma plc
$18
Exeltis, USA Inc.
$18
Merck Sharp & Dohme Corporation
$18
Organon LLC
$17
Ultragenyx Pharmaceutical Inc.
$17
Hikma Pharmaceuticals USA
$14
Top 3 companies account for 65.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Aimovig · BENLYSTA · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · EVUSHELD · Enbrel · FORTEO · HUMIRA · Humira · ILARIS · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · OTREXUP · Otrexup · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Toledo?
Compare rheumatologists in the Toledo area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
14
County median income
$60,095
Nearest hospital to ZIP centroid (approximate)
PROMEDICA TOLEDO HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Alvi is a mixed practice specialist, with above-average Medicare volume (top 16% in OH), with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Alvi experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Alvi performed 12,450 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Alvi receive payments from pharmaceutical companies?
Yes. Dr. Alvi received a total of $7,441 from 27 companies across 222 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alvi's costs compare to other rheumatologists in Toledo?
Dr. Alvi's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alvi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →